Ignite Creation Date:
2024-05-05 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00760916
Status:
WITHDRAWN
Last Update Posted:
2013-01-30
First Post:
2008-09-25
Brief Title:
FREEDOM DR Oral Treprostinil in Combination With an Endothelin Receptor Antagonist ERA andor a Phosphodiesterase-5 PDE-5 Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension PAH
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Organization Data
Organization:
United Therapeutics
Class:
INDUSTRY
Study ID:
TDE-PH-303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
United Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Brett Goetz Associate Manager Clinical Operations
Old Organization:
United Therapeutics